Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

TLR8 inhibition in erythroid cells for inherited non-hemolytic anemia

October 7, 2024 5:31 PM UTC

Inhibiting the innate immune single-stranded RNA sensor TLR8 could help treat inherited non-hemolytic anemia by preventing the disruption of erythropoietin signaling and apoptosis in erythroid cells.

Genetic and phenotypic studies of a male pediatric patient with non-hemolytic anemia and his family identified an X-linked gain-of-function mutation in TLR8...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article